May 05, 2022 10:00 ET | Source: Future Market Insights Global and Consulting Pvt. Ltd. Future Market Insights Global and Consulting Pvt. Ltd.
Valley Cottage, New York, UNITED STATES
NEWARK, Del, May 05, 2022 (GLOBE NEWSWIRE) -- The global rapid infuser market is set to enjoy a valuation of US$ 1.01 Bn in 2022, and further expand at a CAGR of 4.6% to reach US$ 1.52 Bn by the year 2031. According to a recent study by Future Market Insights, reusable devices are leading the market by usability with a share of 74.2% in 2021 within the global market. The market value for rapid infuser holds around 19% of the overall global intravenous infusion pump market which accounts for approximately US$ 5 Bn in 2021.
In a new report, Future Market Insights has provided comprehensive details on essential business strategies that find roles in the rapid infusers market. Market leaders in the industry have been emphasizing on the expansion of their portfolios with efforts on product research. Also, strategic acquisitions are gaining ground in the industry.
Get Sample Copy @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6716
Rapid Infusers Market Key Takeaways
“The global market for rapid infusers is driven by growing number of surgical procedures and high risk of hypothermia and hypovolemia. This product is also widely considered an important intervention in life-threatening ailments such as sepsis. These issues are major influencers in terms of market development through the forecast period,” said a lead analyst from FMI.
Rapid Infusers Market - Who is Winning?
Smith’s Medical, GE Healthcare, BD, 3M Company, Stryker Corporation, ZOLL Medical Corporation, Belmont Instrument, Smisson-Cartledge Biomedical, Kewell Medical Technology Co. Ltd, Teleflex Incorporated, Biegler GmbHALC "TahatAksi"
Covid-19 Impact on Rapid Infusers Market
The COVID-19 pandemic is expected to marginally impact the rapid infusers market. Demand largely remains stable as rapid infusers are standard equipment in most healthcare facilities for critical care applications. The demand for reusable rapid infusers is likely to fall in favor of single-use alternatives, owing to concerns over viral transmission.
Potential disruptions of raw material and component supplies due to lockdown and trade restrictions are concerns. However, the essential natures of the products, makes the industry largely exempt from government restrictions. Demand is unlikely to change substantially even in the post-pandemic period as applications in urology, gynecology, and ICUs continue unabated.
Get Customization @ https://www.futuremarketinsights.com/customization-available/rep-gb-6716
Key Market Segments Covered in Rapid Infuser Industry Research
3.1. Key Trends Impacting the Market
4.4. Rapid Infuser Installed Base Scenario, By Country and Regions
5.1. Current COVID-19 Statistics and Probable Future Impact
5.2. Current GDP Projection and Probable Impact
5.3. Current Economic Projection as compared to 2008 financial analysis
5.6. Recovery Scenario – Short term, Midterm and Long Term Impact
Get Detailed TOC @ https://www.futuremarketinsights.com/toc/rep-gb-6716
The Future Market Insights report has given readers a detailed analysis of the global rapid infusers market, with critical information on historical demand and for forecast statistics (2022 – 2031). The report also encompasses a detailed analysis in terms of costs, pricing, and other major dynamic factors that influence tech developments and production decisions for rapid infusers in varied healthcare applications.
Explore FMI’s Extensive ongoing Coverage on Healthcare
Anti-Asthma TDM Assay Kits Market- The anti-asthma TDM assay kits market is anticipated to grow at a CAGR of 4.5% during the forecast period with a valuation of US$ 18 Bn in 2022.
Intranasal Corticosteroids Market - The global intranasal corticosteroids market is expected to reach US$ 11.4 Billion in 2032 and exhibit immense growth at a CAGR of 7.2% in the forecast period from 2022 to 2032
Antinuclear Antibody Test Market - The antinuclear antibody test market is likely to record a strong CAGR of 8% during the forecast period. The antinuclear antibody test market is currently valued at US$ 7.4 Bn in 2022 and is likely to reach US$ 17.25 Bn by 2032.
Rapid Plasma Reagin Test Market-The rapid plasma reagin test market is likely to register a CAGR of 4% during the forecast period, and is anticipated to reach a market share of US$ 68.51 Mn in 2032, from US$ 46.28 Mn in 2022.
Drainage Catheter Market - The global drainage catheter market size is estimated to reach US$ 325 Mn by the end of 2022. The sales of drainage catheters are expected to exceed a valuation of US$ 490 Mn by 2032, in comparison to the US$ 310 registered in the year 2021
About Future Market Insights (FMI)
Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.
Future Market Insights Inc. Christiana Corporate, 200 Continental Drive, Suite 401, Newark, Delaware - 19713, USA T: +1-845-579-5705 For Sales Enquiries: sales@futuremarketinsights.com Website: https://www.futuremarketinsights.com Report: https://www.futuremarketinsights.com/reports/rapid-infuser-market LinkedIn| Twitter| Blogs